Paralysis News and Research

RSS
Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.
Two existing drugs may potentially become new drug target for multiple sclerosis

Two existing drugs may potentially become new drug target for multiple sclerosis

Toxic Botox travels through our nerves to reach central nervous system

Toxic Botox travels through our nerves to reach central nervous system

Polio immunization campaign targets 5.8 million children in Iraq

Polio immunization campaign targets 5.8 million children in Iraq

National MS Society commits $28 million to support new MS research projects, training awards

National MS Society commits $28 million to support new MS research projects, training awards

New review highlights future research initiatives to eradicate polio

New review highlights future research initiatives to eradicate polio

Researchers test effects of light therapy on brain function

Researchers test effects of light therapy on brain function

One in five college students experiences exploding head syndrome

One in five college students experiences exploding head syndrome

Preventing falls in care homes: an interview with Professor Pip Logan

Preventing falls in care homes: an interview with Professor Pip Logan

Cancer drug promotes neuronal regeneration after spinal cord injury

Cancer drug promotes neuronal regeneration after spinal cord injury

Wings for Life World Run to fund breakthrough clinical study on spinal cord injury

Wings for Life World Run to fund breakthrough clinical study on spinal cord injury

Asterias begins enrollment for AST-OPC1 Phase 1/2a trial to treat complete cervical spinal cord injury

Asterias begins enrollment for AST-OPC1 Phase 1/2a trial to treat complete cervical spinal cord injury

New pharmacological compounds block nerve cell damage in mouse models of MS

New pharmacological compounds block nerve cell damage in mouse models of MS

Christopher & Dana Reeve Foundation announces Quality of Life grants for 75 nonprofit organizations

Christopher & Dana Reeve Foundation announces Quality of Life grants for 75 nonprofit organizations

Experts provide suggestions to prevent neurological injuries associated with epidural steroid injections

Experts provide suggestions to prevent neurological injuries associated with epidural steroid injections

Health Canada: Parents advised not to feed honey to infants less than one year old

Health Canada: Parents advised not to feed honey to infants less than one year old

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

ISP shows promise in stopping fatal arrhythmias after heart attack

ISP shows promise in stopping fatal arrhythmias after heart attack

UCLA offers new hope to patients suffering from phrenic nerve damage

UCLA offers new hope to patients suffering from phrenic nerve damage

Scientists reveal mechanism underlying cellular degeneration of upper motor neurons

Scientists reveal mechanism underlying cellular degeneration of upper motor neurons

Rare respiratory virus could be linked to severe neurological illness in children

Rare respiratory virus could be linked to severe neurological illness in children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.